Serum Antibody Response to Moraxella Catarrhalis Proteins OMP CD, OppA, Msp22, Hag, and PilA2 After Nasopharyngeal Colonization and Acute Otitis Media in Children

Overview

Journal Vaccine

Specialty Allergy & Immunology

Date 2015 Sep 23

PMID 26392013

Citations 13

Authors

Dabin Ren

Anthony L Almudevar

Timothy F Murphy

Eric R Lafontaine

Anthony A Campagnari

Nicole Luke-Marshall

Janet R Casey

Michael E Pichichero

Affiliations

Soon will be listed here.

Abstract

Background: There is no licensed vaccine for Moraxella catarrhalis (Mcat), which is a prominent bacterium causing acute otitis media (AOM) in children and lower respiratory tract infections in adults. Nasopharyngeal (NP) colonization caused by respiratory bacteria results in natural immunization of the host. To identify Mcat antigens as vaccine candidates, we evaluated the development of naturally induced antibodies to 5 Mcat surface proteins in children 6-30 months of age during Mcat NP colonization and AOM.

Methods: Human serum IgG against the recombinant Mcat proteins, outer membrane protein (OMP) CD, oligopeptide permease (Opp)A, hemagglutinin (Hag), Moraxella surface protein (Msp)22, and PilA clade 2 (PilA2) was quantitated by using an ELISA assay.

Results: There were 223 Mcat NP colonization episodes documented in 111 (60%) of 184 children in the study. Thirty five Mcat AOM episodes occurred in 30 (16%) of 184 children. All 5 Mcat candidate vaccine antigens evaluated stimulated a significant rise in serum IgG levles over time from 6 to 36 months of age (P<0.001), with a rank order as follows: Msp22=OppA>OMP CD=Hag=PilA2. Children with no detectable Mcat NP colonization showed a higher serum IgG level against OppA, Hag, and Msp22 compared to those with Mcat NP colonization (P<0.05). Individual data showed that some children responded to AOM with an antibody increase to one or more of the studied Mcat proteins but some children failed to respond.

Conclusions: Serum antibody to Mcat candidate vaccine proteins OMP CD, OppA, Msp22, Hag, and PilA2 increased with age in naturally immunized children age 6-30 months following Mcat NP colonization and AOM. High antibody levels against OppA, Msp22, and Hag correlated with reduced carriage. The results support further investigation of these vaccine candidates in protecting against Mcat colonization and infection.

Citing Articles

Immunoglobulins and Transcription Factors in Otitis Media.

Jung S, Kim D, Park D, Lee E, Choi Y, Ryu J Int J Mol Sci. 2021; 22(6).

PMID: 33801155 PMC: 8004237. DOI: 10.3390/ijms22063201.

Synchrony in serum antibody response to conserved proteins of in young children.

Ren D, Bajorski P, Murphy T, Lafontaine E, E Pichichero M Hum Vaccin Immunother. 2020; 16(12):3194-3200.

PMID: 32401688 PMC: 8641602. DOI: 10.1080/21645515.2020.1752562.

Panel 8: Vaccines and immunology.

Alderson M, Murphy T, Pelton S, Novotny L, Hammitt L, Kurabi A Int J Pediatr Otorhinolaryngol. 2020; 130 Suppl 1:109839.

PMID: 31948716 PMC: 7153269. DOI: 10.1016/j.ijporl.2019.109839.

Panel 7 - Pathogenesis of otitis media - a review of the literature between 2015 and 2019.

Thornton R, Hakansson A, Hood D, Nokso-Koivisto J, Preciado D, Riesbeck K Int J Pediatr Otorhinolaryngol. 2019; 130 Suppl 1:109838.

PMID: 31879085 PMC: 7062565. DOI: 10.1016/j.ijporl.2019.109838.

Increased growth rate and amikacin resistance of Salmonella enteritidis after one-month spaceflight on China's Shenzhou-11 spacecraft.

Zhang B, Bai P, Zhao X, Yu Y, Zhang X, Li D Microbiologyopen. 2019; 8(9):e00833.

PMID: 30912318 PMC: 6741137. DOI: 10.1002/mbo3.833.

References

Murphy T, Kirkham C, Liu D, Sethi S . Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease. Infect Immun. 2003; 71(3):1288-94. PMC: 148877. DOI: 10.1128/IAI.71.3.1288-1294.2003. View

Smidt M, Battig P, Verhaegh S, Niebisch A, Hanner M, Selak S . Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model. PLoS One. 2013; 8(5):e64422. PMC: 3650003. DOI: 10.1371/journal.pone.0064422. View

Jones M, Johnson A, Koszelak-Rosenblum M, Kirkham C, Brauer A, Malkowski M . Role of the oligopeptide permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract. Infect Immun. 2014; 82(11):4758-66. PMC: 4249328. DOI: 10.1128/IAI.02185-14. View

Kaplan B, Wandstrat T, Cunningham J . Overall cost in the treatment of otitis media. Pediatr Infect Dis J. 1997; 16(2 Suppl):S9-11. DOI: 10.1097/00006454-199702001-00003. View

Murphy T, Brauer A, Aebi C, Sethi S . Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Infect Immun. 2005; 73(6):3471-8. PMC: 1111810. DOI: 10.1128/IAI.73.6.3471-3478.2005. View

Murphy T, Brauer A, Grant B, Sethi S . Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med. 2005; 172(2):195-9. PMC: 2718466. DOI: 10.1164/rccm.200412-1747OC. View

Ruckdeschel E, Kirkham C, Lesse A, Hu Z, Murphy T . Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Infect Immun. 2008; 76(4):1599-607. PMC: 2292845. DOI: 10.1128/IAI.01253-07. View

Tan T, Riesbeck K . Current progress of adhesins as vaccine candidates for Moraxella catarrhalis. Expert Rev Vaccines. 2008; 6(6):949-56. DOI: 10.1586/14760584.6.6.949. View

Mawas F, Ho M, Corbel M . Current progress with Moraxella catarrhalis antigens as vaccine candidates. Expert Rev Vaccines. 2008; 8(1):77-90. DOI: 10.1586/14760584.8.1.77. View

10.

Lafontaine E, Snipes L, Bullard B, Brauer A, Sethi S, Murphy T . Identification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis. Clin Vaccine Immunol. 2009; 16(5):653-9. PMC: 2681595. DOI: 10.1128/CVI.00460-08. View

11.

Murphy T, Parameswaran G . Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis. 2009; 49(1):124-31. DOI: 10.1086/599375. View

12.

E Pichichero M, Kaur R, Casey J, Sabirov A, Khan M, Almudevar A . Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 2010; 28(44):7184-92. PMC: 3959881. DOI: 10.1016/j.vaccine.2010.08.063. View

13.

Yang M, Johnson A, Murphy T . Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen. Infect Immun. 2010; 79(2):846-57. PMC: 3028828. DOI: 10.1128/IAI.00314-10. View

14.

Luke-Marshall N, Sauberan S, Campagnari A . Comparative analyses of the Moraxella catarrhalis type-IV pilus structural subunit PilA. Gene. 2011; 477(1-2):19-23. DOI: 10.1016/j.gene.2011.01.010. View

15.

Verhaegh S, de Vogel C, Riesbeck K, Lafontaine E, Murphy T, Verbrugh H . Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants. Vaccine. 2011; 29(34):5603-10. DOI: 10.1016/j.vaccine.2011.06.019. View

16.

Liu K, E Pichichero M . Clinical significance of serum S100A12 in acute otitis media in young children. Pediatr Infect Dis J. 2011; 31(3):e56-8. PMC: 3308144. DOI: 10.1097/INF.0b013e31824672cb. View

17.

Verhaegh S, Stol K, de Vogel C, Riesbeck K, Lafontaine E, Murphy T . Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion. Clin Vaccine Immunol. 2012; 19(6):914-8. PMC: 3370449. DOI: 10.1128/CVI.05630-11. View

18.

Su Y, Singh B, Riesbeck K . Moraxella catarrhalis: from interactions with the host immune system to vaccine development. Future Microbiol. 2012; 7(9):1073-100. DOI: 10.2217/fmb.12.80. View

19.

E Pichichero M, Kaur R, Casey J, Xu Q, Almudevar A, Ochs M . Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children. Hum Vaccin Immunother. 2012; 8(6):799-805. PMC: 3679215. DOI: 10.4161/hv.19820. View

20.

Xu Q, Casey J, Pichichero M . Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children. Mucosal Immunol. 2015; 8(5):1110-7. PMC: 4524797. DOI: 10.1038/mi.2015.1. View